Delcath Systems (DCTH) Change in Accured Expenses (2010 - 2026)
Delcath Systems' (DCTH) quarterly Change in Accured Expenses came in at -$273000.0 in Q1 2026, up 70.49% year-on-year from -$160130.0 in Q1 2025, and down 109.2% quarter-over-quarter from $3.0 million in Q4 2025.
Delcath Systems (DCTH) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Delcath Systems' Change in Accured Expenses history runs 17 years deep, the most recent figure standing at -$273000.0 for Q1 2026.
- On a quarterly basis, Change in Accured Expenses rose 70.49% year-over-year to -$273000.0 in Q1 2026; TTM through Mar 2026 was $5.4 million, a 8781.97% increase from a year earlier, with the FY2025 full-year figure at $4.8 million, up 894.99% from the prior year.
- Change in Accured Expenses declined to -$273000.0 in Q1 2026 per DCTH's latest filing, from $3.0 million in the prior quarter.
- Across five years, Change in Accured Expenses topped out at $5.1 million in Q2 2025 and bottomed at -$3.1 million in Q2 2023.
- The 5-year median for Change in Accured Expenses is $238000.0 (2023), against an average of $386529.4.
- Across the five-year window, Change in Accured Expenses tumbled 337.08% in 2023 and soared 726.18% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at -$1.1 million in 2022, then soared by 121.46% to $238000.0 in 2023, then jumped by 50.84% to $359000.0 in 2024, then surged by 726.18% to $3.0 million in 2025, then plunged by 109.2% to -$273000.0 in 2026.
- Per Business Quant, the three latest DCTH Change in Accured Expenses figures stand at -$273000.0 (Q1 2026), $3.0 million (Q4 2025), and -$2.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.73 Bn | 176.43 Bn | 6.27 Bn | - |
| 2 | Stryker | 129.05 Bn | 126.17 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 108.52 Bn | 99.30 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 68.63 Bn | 67.18 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 48.43 Bn | 44.76 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 28.36 Bn | 27.24 Bn | 750.30 Mn | 145.10 Mn |
| 7 | GE HealthCare Technologies | 28.14 Bn | 25.85 Bn | 1.98 Bn | -250.00 Mn |
| 8 | Smith & Nephew | 26.89 Bn | 26.32 Bn | - | - |
| 9 | Koninklijke Philips | 24.25 Bn | 21.12 Bn | 2.07 Bn | 21.07 Mn |
| 10 | Delcath Systems | 431.53 Mn | 342.24 Mn | 21.26 Mn | -273,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -273,000.00 |
| Mar 31, 2026 | -273,000.00 |
| Dec 31, 2025 | 2.97 Mn |
| Dec 31, 2025 | 2.97 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Sep 30, 2025 | -2.34 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Jun 30, 2025 | 5.06 Mn |
| Mar 31, 2025 | -925,000.00 |
| Mar 31, 2025 | -925,000.00 |
| Dec 31, 2024 | 359,000.00 |
| Dec 31, 2024 | 359,000.00 |
| Sep 30, 2024 | -1.22 Mn |
| Sep 30, 2024 | -1.22 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Jun 30, 2024 | 1.85 Mn |
| Mar 31, 2024 | -507,000.00 |
| Mar 31, 2024 | -507,000.00 |
| Dec 31, 2023 | 238,000.00 |
| Dec 31, 2023 | 238,000.00 |